OptimizeRx (OPRX) Total Non-Current Liabilities (2010 - 2021)

OptimizeRx (OPRX) has 12 years of Total Non-Current Liabilities data on file, last reported at $260614.0 in Q3 2021.

• For the quarter ending Q3 2021, Total Non-Current Liabilities fell 26.92% year-over-year to $260614.0; the trailing twelve-month figure through Sep 2021 stood at $260614.0 (down 26.92% YoY), and the FY2020 full-year result was $325533.0, down 94.26% from the prior year.
• Total Non-Current Liabilities eased to $260614.0 in Q3 2021, from $282934.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $17.4 million in Q2 2018 to a low of $260614.0 in Q3 2021.
• A 5-year average of $3.9 million and a median of $2.2 million in 2017 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 139.69% in 2019 and sank 94.26% in 2020, its largest moves.
• Tracing OPRX's Total Non-Current Liabilities over 5 years: stood at $2.3 million in 2017, then gained by 4.8% to $2.4 million in 2018, then soared by 139.69% to $5.7 million in 2019, then slumped by 94.26% to $325533.0 in 2020, then declined by 19.94% to $260614.0 in 2021.
• Business Quant data shows OPRX's Total Non-Current Liabilities at $260614.0 in Q3 2021, $282934.0 in Q2 2021, and $305039.0 in Q1 2021.